Hypotension	hypotension	O	DISEASE	OTHERS	I
,	,	O	O	O	O
bradycardia	bradycardia	O	DISEASE	OTHERS	I
,	,	O	O	O	O
and	and	O	O	O	O
asystole	asystole	O	DISEASE	OTHERS	I
after	after	O	O	O	O
high-dose	high-dose	O	O	O	O
intravenous	intravenous	O	O	O	O
methylprednisolone	methylprednisolone	CHEMICALS	O	OTHERS	I
in	in	O	O	O	O
a	a	O	O	O	O
monitored	monitored	O	O	O	O
patient	patient	O	O	O	O
.	.	O	O	O	O

We	we	O	O	O	O
report	report	O	O	O	O
a	a	O	O	O	O
case	case	O	O	O	O
of	of	O	O	O	O
hypotension	hypotension	O	DISEASE	OTHERS	I
,	,	O	O	O	O
bradycardia	bradycardia	O	DISEASE	OTHERS	I
,	,	O	O	O	O
and	and	O	O	O	O
asystole	asystole	O	DISEASE	OTHERS	I
after	after	O	O	O	O
intravenous	intravenous	O	O	O	O
administration	administration	O	O	O	O
of	of	O	O	O	O
high-dose	high-dose	O	O	O	O
methylprednisolone	methylprednisolone	CHEMICALS	O	OTHERS	I
in	in	O	O	O	O
a	a	O	O	O	O
73-year-old	73-year-old	O	O	O	O
patient	patient	O	O	O	O
who	who	O	O	O	O
underwent	underwent	O	O	O	O
electrocardiographic	electrocardiographic	O	O	O	O
(	(	O	O	O	O
ECG	ecg	O	O	O	O
)	)	O	O	O	O
monitoring	monitoring	O	O	O	O
throughout	throughout	O	O	O	O
the	the	O	O	O	O
episode	episode	O	O	O	O
.	.	O	O	O	O

There	there	O	O	O	O
was	was	O	O	O	O
a	a	O	O	O	O
history	history	O	O	O	O
of	of	O	O	O	O
ischemic	ischemic	O	O	OTHERS	I
cardiac	cardiac	O	DISEASE	OTHERS	I
disease	disease	O	DISEASE	OTHERS	I
9	9	O	O	O	O
years	years	O	O	O	O
earlier	earlier	O	O	O	O
.	.	O	O	O	O

The	the	O	O	O	O
patient	patient	O	O	O	O
was	was	O	O	O	O
admitted	admitted	O	O	O	O
with	with	O	O	O	O
a	a	O	O	O	O
pulmonary-renal	pulmonary-renal	O	O	O	O
syndrome	syndrome	O	O	O	O
with	with	O	O	O	O
hemoptysis	hemoptysis	O	O	OTHERS	I
,	,	O	O	O	O
rapidly	rapidly	O	O	O	O
progressive	progressive	O	O	OTHERS	I
renal	renal	O	DISEASE	OTHERS	I
failure	failure	O	DISEASE	OTHERS	I
,	,	O	O	O	O
and	and	O	O	O	O
hypoxemia	hypoxemia	O	O	OTHERS	I
that	that	O	O	O	O
required	required	O	O	O	O
mechanical	mechanical	O	O	O	O
ventilation	ventilation	O	O	O	O
in	in	O	O	O	O
the	the	O	O	O	O
intensive	intensive	O	O	O	O
care	care	O	O	O	O
unit	unit	O	O	O	O
.	.	O	O	O	O

After	after	O	O	O	O
receiving	receiving	O	O	O	O
advanced	advanced	O	O	O	O
cardiopulmonary	cardiopulmonary	O	O	O	O
resuscitation	resuscitation	O	O	O	O
,	,	O	O	O	O
the	the	O	O	O	O
patient	patient	O	O	O	O
recovered	recovered	O	O	O	O
cardiac	cardiac	O	O	O	O
rhythm	rhythm	O	O	O	O
.	.	O	O	O	O

The	the	O	O	O	O
ECG	ecg	O	O	O	O
showed	showed	O	O	O	O
a	a	O	O	O	O
junctional	junctional	O	O	O	O
rhythm	rhythm	O	O	O	O
without	without	O	O	O	O
ventricular	ventricular	O	O	OTHERS	I
arrhythmia	arrhythmia	O	DISEASE	OTHERS	I
.	.	O	O	O	O

This	this	O	O	O	O
study	study	O	O	O	O
reviews	reviews	O	O	O	O
the	the	O	O	O	O
current	current	O	O	O	O
proposed	proposed	O	O	O	O
mechanisms	mechanisms	O	O	O	O
of	of	O	O	O	O
sudden	sudden	O	O	OTHERS	I
death	death	O	DISEASE	OTHERS	I
after	after	O	O	O	O
a	a	O	O	O	O
high	high	O	O	O	O
dose	dose	O	O	O	O
of	of	O	O	O	O
intravenous	intravenous	O	O	O	O
methylprednisolone	methylprednisolone	CHEMICALS	O	OTHERS	I
(	(	O	O	O	O
IVMP	ivmp	O	O	OTHERS	I
)	)	O	O	O	O
.	.	O	O	O	O

These	these	O	O	O	O
mechanisms	mechanisms	O	O	O	O
are	are	O	O	O	O
not	not	O	O	O	O
well	well	O	O	O	O
understood	understood	O	O	O	O
because	because	O	O	O	O
,	,	O	O	O	O
in	in	O	O	O	O
most	most	O	O	O	O
cases	cases	O	O	O	O
,	,	O	O	O	O
the	the	O	O	O	O
patients	patients	O	O	O	O
were	were	O	O	O	O
not	not	O	O	O	O
monitored	monitored	O	O	O	O
at	at	O	O	O	O
the	the	O	O	O	O
moment	moment	O	O	O	O
of	of	O	O	O	O
the	the	O	O	O	O
event	event	O	O	O	O
.	.	O	O	O	O

Rapid	rapid	O	O	O	O
infusion	infusion	O	O	O	O
and	and	O	O	O	O
underlying	underlying	O	O	O	O
cardiac	cardiac	O	DISEASE	OTHERS	I
disease	disease	O	DISEASE	OTHERS	I
were	were	O	O	O	O
important	important	O	O	O	O
risk	risk	O	O	O	O
factors	factors	O	O	O	O
in	in	O	O	O	O
the	the	O	O	O	O
case	case	O	O	O	O
reported	reported	O	O	O	O
here	here	O	O	O	O
,	,	O	O	O	O
and	and	O	O	O	O
the	the	O	O	O	O
authors	authors	O	O	O	O
discount	discount	O	O	O	O
ventricular	ventricular	O	O	OTHERS	I
arrhythmia	arrhythmia	O	DISEASE	OTHERS	I
as	as	O	O	O	O
the	the	O	O	O	O
main	main	O	O	O	O
mechanism	mechanism	O	O	O	O
.	.	O	O	O	O

